Visualizing the landscape of ocular melanoma research: a bibliometric analysis

Dublin Core

Title

Visualizing the landscape of ocular melanoma research: a bibliometric analysis

Subject

Uveal, Ocular, Melanoma, Ocular melanoma

Description

Abstract
Introduction Ocular melanoma is a type of malignancy affecting the eye. Symptoms can include dark spots near or
around the iris or the mucous membrane of the eyes. Treatments include radiation, laser therapy, and enucleation or
evisceration of the eye.
Method A bibliometric analysis was conducted using the database Web of Science. VosViewer version 1.6.20 was
utilized to import tab-delimited files and visualize the data from Web of Science.
Results Data was collected from 1990 to 2024, with 2021 being the highest publication year (258). The U.S. (1,950),
Germany (405), and England (205) released the greatest number of publications. From those countries, Thomas
Jefferson University and Leiden University released the largest number of articles written about ocular melanoma.
Conclusion Ocular melanoma is a rare type of cancer affecting people worldwide. As medicinal research advances
over time, the ability to prevent and treat ocular melanoma steadily improves. Over the past years (1990–2024), there
has been a general increase in the number of publications regarding ocular melanoma. There have been gaps in
the research in South Asian and African demographics, showing that these communities have not brought enough
attention to this disease.
Keywords Uveal, Ocular, Melanoma, Ocular melanoma

Creator

Maya Lee1 , Ethan Nichols2 , Vindhya N. Reddy3 and Latha Ganti4*

Source

https://doi.org/10.1186/s12245-025-01018-8

Date

2025

Contributor

Peri Irawan

Format

pdf

Language

english

Type

text

Files

Citation

Maya Lee1 , Ethan Nichols2 , Vindhya N. Reddy3 and Latha Ganti4*, “Visualizing the landscape of ocular melanoma research: a bibliometric analysis,” Repository Horizon University Indonesia, accessed April 11, 2026, https://repository.horizon.ac.id/items/show/12856.